sk&f 83959 has been researched along with u 0126 in 1 studies
Studies (sk&f 83959) | Trials (sk&f 83959) | Recent Studies (post-2010) (sk&f 83959) | Studies (u 0126) | Trials (u 0126) | Recent Studies (post-2010) (u 0126) |
---|---|---|---|---|---|
94 | 0 | 46 | 2,816 | 2 | 1,213 |
Protein | Taxonomy | sk&f 83959 (IC50) | u 0126 (IC50) |
---|---|---|---|
RAF proto-oncogene serine/threonine-protein kinase | Homo sapiens (human) | 0.29 | |
Serine/threonine-protein kinase B-raf | Homo sapiens (human) | 0.25 | |
Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | 0.07 | |
Dual specificity mitogen-activated protein kinase kinase 2 | Homo sapiens (human) | 0.2816 | |
Dual specificity mitogen-activated protein kinase kinase 1 | Homo sapiens (human) | 0.2529 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fan, B; Li, GY; Li, T; Ma, TH; Zheng, YC | 1 |
1 other study(ies) available for sk&f 83959 and u 0126
Article | Year |
---|---|
The D₁ dopamine receptor agonist, SKF83959, attenuates hydrogen peroxide-induced injury in RGC-5 cells involving the extracellular signal-regulated kinase/p38 pathways.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Butadienes; Cell Line; Dopamine Agonists; Dopamine Antagonists; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Hydrogen Peroxide; Imidazoles; JNK Mitogen-Activated Protein Kinases; Mice; Nitriles; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Pyridines; Rats; Receptors, Dopamine D1; Retinal Ganglion Cells; Signal Transduction | 2012 |